Which attribute describes how easy it is to understand and use an innovation?

Study for the WHO Models, Health Policy and Culture in Health Care Test. Engage with flashcards and multiple choice questions. Gain insights into WHO models and global health policy. Prepare effectively for your exam with tailored study materials.

Multiple Choice

Which attribute describes how easy it is to understand and use an innovation?

Explanation:
In diffusion of innovations, how easy it is to understand and use an innovation is described by its complexity. Complexity measures the perceived difficulty of learning and applying the new idea. When an innovation is simple to learn and integrate into existing workflows, people are more likely to adopt it quickly, especially in health care where time and training matter. If something is viewed as highly complex, it creates a barrier to adoption because clinicians must invest more effort to understand and use it. Relative advantage refers to how much better the new approach is than what’s currently used, not how hard it is to grasp. Observability is about how visible the results are to others, which can drive adoption through demonstrated benefits. Trialability concerns how easily the innovation can be tested on a limited basis, which affects risk and experimentation, not the inherent ease of use.

In diffusion of innovations, how easy it is to understand and use an innovation is described by its complexity. Complexity measures the perceived difficulty of learning and applying the new idea. When an innovation is simple to learn and integrate into existing workflows, people are more likely to adopt it quickly, especially in health care where time and training matter. If something is viewed as highly complex, it creates a barrier to adoption because clinicians must invest more effort to understand and use it.

Relative advantage refers to how much better the new approach is than what’s currently used, not how hard it is to grasp. Observability is about how visible the results are to others, which can drive adoption through demonstrated benefits. Trialability concerns how easily the innovation can be tested on a limited basis, which affects risk and experimentation, not the inherent ease of use.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy